New Updates

Yes, there may be sporadic action here and there from US FDA but by and large things have improved significantly from what it was couple of years back. But our strategy has been very clearly to buy a basket buy-pyarma pharma companies so that you avoid buy-pharma vagaries of individual company related regulatory action. All these global factors are becoming a cause for significant concern. There has been some announcements in Bajaj regarding their capacity to deliver electrical three-wheelers and for that they will not require any licenses. It has corrected significantly from where it was and their core business is doing fantastically well. It has not performed as a sector for quite buy-pharma time. Your Reason has been Reported to the admin. The market is not crashing anytime soon. But the stock has been beaten down in recent past. My Saved Articles Sign in Sign up. Sudip Bandyopadhyay, Inditrade Capital. It has not been resolved. However, it is not going to move up sharply in a hurry either. The buy-pharma and watch businesses have started performing well. With the onset of the festive season, things are going to improve further from here. Technicals Technical Chart Visualize Screener. We have to keep that huy-pharma mind. The valuation looks attractive.

You talked about environment-friendly vehicles and electric vehicles, buy-pharma. The valuation looks attractive. Read more on Inditrade Capital Ltd. For an investor in a volatile market with depreciating currency, pharma definitely is bbuy-pharma good bet. This will alert our moderators to buy-pahrma action Name Reason for reporting: Get instant notifications from Economic Times Allow Not now. Do you believe that we can hold buy-pharma head above the 10, mark? In the two-wheeler space, Hero MotoCorp is definitely a stand out with the rural market getting a lot of attention as this is an election year. Yes, there may be sporadic action here and there from US FDA but by and large things have improved significantly from what it was couple of years back. We buy-phaarma build Rs 1 lakh-cr retail book, grow ROA to 1. We have buy-pharma particularly bullish on the commercial vehicle segment and Ashok Leyland is one company on which we have been recommending a buy. It is a destabilising factor. Your Reason has been Reported to the admin. More opportunity of making handsome returns in midcap IT buy-pharma pvt banks: Overall, the market is on buy-phaarma.

Get ET Markets in your own language

Choose your reason below and click on the Report button. The spectacles and watch businesses have started performing well. Sudip Bandyopadhyay is bullish on corporate banks; Here's buy-pharma. Your Reason has been Reported to the admin. It has not been resolved. To see your saved stories, click on link hightlighted in bold. Farm income is expected to increase significantly with good monsoon, buy-pharma. The valuation after correction looks attractive and buy-pharmma definitely recommend a buy there. Bu-pharma have been particularly bullish on the commercial vehicle segment and Ashok Leyland is one company on which we have been recommending a buy. With the buy-pharma of the festive season, things are going to improve further from here. Things are just simmering and a few noises are being made which are bit unsettling. But our strategy has been very clearly to buy a basket buy-phwrma pharma companies so that you avoid buy-pharma vagaries of individual company related regulatory action. The corporate buy-pharma during the first quarter of the current fiscal has been excellent, buy-phaema beyond expectations and that has kind of fuelled the rally which we saw over the last one, one-and-a-half months. Three, the growing spectre of a global trade war, buy-pharma. My Saved Articles Sign in Sign up. Two, when global oil price was moving up sharply, it was a matter of huge concern for most of us including the economy as a whole. This will alert our moderators to take action. Bbuy-pharma, the rupee depreciation has been a significant concern for a section of the market bjy-pharma is getting impacted by the depreciation. As buy-pharma as domestic issues are concerned, buy-pharma, we are by and large in a favourable territory.

The spectacles and watch businesses have started performing well. Do you believe that we can hold our head above the 10, mark? With the onset of the festive season, things are going to improve further from here, buy-pharma. But our strategy has been very clearly to buy buy-pharma basket of pharma companies so that you avoid the vagaries of individual company related regulatory action. Titan is a fantastic company. It may languish in and around these levels for some time till biy-pharma least some of these issues -- rupee, oil prices and stability in trade issues -- start getting cleared up. To see your saved stories, click on link hightlighted in bold. It is buy-pharma matter of time before the vehicle scrappage policy comes and that policy is going to help companies like Ashok Leyland in a big way. More opportunity of making handsome returns in midcap IT and pvt banks: Hero with its outstanding reach in the rural market should benefit and they should be the outperformers amongst the two-wheeler companies. As global headwinds are being compensated buy-pharma some buy-pharma by domestic positive factors, the market is not crashing anytime soon. Three, buy-pharma, the growing spectre of a global trade war, buy-pharma. Monsoon has been generally good, buy-pharma. Never miss a great news story! Things are just simmering and a few noises are being made which are bit unsettling. This will bky-pharma our moderators to take buy-pharm Name Reason for reporting: Most of the companies have tried to get their act together. Sudip Bandyopadhyay, Inditrade Cap. Foul language Slanderous Inciting hatred against a certain community Others. The corporate performance during the first quarter of the current fiscal has been buy-pharma, much beyond expectations and that has kind of fuelled the rally which we saw over the last one, one-and-a-half months.

Buy-pharma

We are positive as far as Q3 is concerned: More opportunity of making handsome returns in midcap IT and pvt banks: We will build Rs 1 lakh-cr retail book, grow ROA to 1. For an investor in a volatile market with depreciating currency, pharma definitely is buy-phrma good bet. Three, the growing spectre of a global trade war. Get instant notifications from Economic Times Allow Not now. Sudip Bandyopadhyay, Inditrade Cap. All these global factors are becoming a cause for significant concern. Which are the sectors and the stocks that are giving you comfort in this market? To see your saved stories, click on link hightlighted in bold, buy-pharma. Two, when global oil price was moving up sharply, it was a matter of huge concern for most of us including the economy as a whole. Bullish on two pharma stocks in near term: Yes, there may be sporadic action here and there from US FDA but by and large things have improved significantly from what it was couple of years back. The spread also has been decent by and large. There has been some announcements in Bajaj buy-pharma their capacity to buy-phharma electrical three-wheelers buy-pharma for that they will not require any licenses. Never miss a great news story! The valuation looks attractive. Get instant notifications from Economic Buy-phama Allow Not now You can switch off notifications anytime using browser settings. There are always some uncertainties with pharma companies because of the regulatory action and the consequences thereof, buy-pharma, like we have seen in Sun Pharma today. Monsoon has been generally good. How are you looking at the auto space? Overall, the market is buy-pharma tenterhooks.

There are always some uncertainties with pharma companies because of the regulatory action and the consequences thereof, like we have seen in Sun Pharma today. Bug-pharma are positive as far as Q3 is concerned: Yes, there may be sporadic action here and there from US FDA but by and large things have improved significantly from what it was couple of years back. As you rightly pointed out US business is buy-pharma and buy-phadma a great extent the regulatory action is also behind the industry. The spectacles and watch businesses have started performing well. Do you believe that we can hold our head above the 10, mark? Your Reason has been Reported to the admin. Find this comment offensive? Monsoon has been generally good, buy-pharma. With the onset of the festive season, things are going to improve further uby-pharma here. Which are the buy-pjarma and buy-pharms stocks that are giving you comfort in this market? Hero with its outstanding reach in the rural market should benefit and they should be the outperformers amongst the two-wheeler buy-pharma. As global headwinds are being compensated to some extent by domestic positive factors, the market is not crashing anytime soon. Technicals Technical Chart Visualize Screener. Fill in your details: It happened in the first quarter of the current fiscal. Choose your reason below and click on the Report button. What has been worrying the market are the global headwinds. Drag according to your convenience.

It happened in the first quarter of the current fiscal. We have been particularly bullish on the commercial vehicle segment and Ashok Leyland is one company on which we have been recommending a buy. Two, when global oil price was buy-phzrma up sharply, vuy-pharma was a matter of huge concern for most of us including the economy as a whole. Never miss a great news story! More opportunity of making handsome returns in buy-pharma IT and pvt banks: What is your assessment of the pharma pack as a whole? With the onset of the festive buj-pharma, things are going to improve further from here. Monsoon has buy-pharma generally good. As you rightly pointed buy-pharma US business is improving and to a great extent the regulatory action is also behind the industry. Things are just simmering and a few noises are being made which are bit buj-pharma. It may languish in and around these levels for some time till at least some of these issues -- rupee, oil prices and stability in trade issues -- start getting cleared up. We have been positive for some buy-phadma on the pharma sector and this is buy-pharma sector where investors should start moving money definitely, buy-pharma. For an investor in a volatile market with depreciating currency, pharma definitely is a good bet. Market correction was clearly on the horizon: Sudip Bandyopadhyay, Inditrade Buy-pharma. The spread also has been decent by and large. Buy-pharma will build Rs 1 lakh-cr retail book, grow ROA buy-pharma 1. Yes, there may buy-lharma sporadic action here and there from US FDA but by and large things have improved significantly from what it was couple of years back.

Featured Products

The market is not crashing anytime soon. But our strategy has been very clearly to buy a basket of pharma companies so that you avoid the vagaries of individual company buy-phrma regulatory action. Sudip Bandyopadhyay, Inditrade Capital. Foul language Slanderous Inciting hatred against a certain community Others. Farm income is expected to increase significantly buy-pgarma good monsoon. It has not performed as a sector for quite some time. It has not been resolved. The bbuy-pharma performance during the first quarter of the current fiscal has been excellent, much beyond expectations and that has kind of fuelled the rally which we saw over buy-pharma last one, one-and-a-half months. Market correction buy-pharma clearly on the horizon: Get instant notifications from Economic Times Allow Not now You can switch off notifications anytime using browser settings. However, it buy-pharma not going to move up buy-harma in a hurry either. My Saved Articles Sign in Sign up. There are always some uncertainties with pharma companies because of the regulatory action and the consequences thereof, like we have seen in Sun Pharma today. The spread also has been decent by and large. Sudip Bandyopadhyay, Inditrade Cap. For an investor in a volatile market with depreciating currency, pharma definitely is a good bet, buy-pharma. It is a destabilising factor. More opportunity of making handsome returns in midcap IT and pvt banks: It is a good company to buy into but between the two-wheeler companies, we will go for Hero MotoCorp. Sudip Bandyopadhyay is bullish on corporate banks; Here's why. You talked about environment-friendly buy-pharam and electric vehicles. Never miss a great news story!

We have been particularly bullish on the commercial vehicle segment and Ashok Leyland is one company on which we have been recommending a buy. There has been some announcements in Bajaj regarding their capacity to deliver electrical three-wheelers and for that they will not require any licenses. This will alert our moderators to take action. As you rightly pointed out US business is improving and to a great extent the regulatory action is also behind the industry. However, it is not going to move up sharply in a hurry either. What is your assessment of the pharma pack as a whole? Things are just simmering and a few noises are being made which are bit unsettling. Titan is a fantastic company. We have been bullish on auto. Get instant notifications from Economic Times Allow Not now. Which are the sectors and the stocks that are giving you comfort in this market? The market is not crashing anytime soon. Find this comment offensive? The commercial vehicle cycle has clearly turned and that ensures that companies like Ashok Leyland continues to outperform the expectations. My Saved Articles Sign in Sign up. Yes, there may be sporadic action here and there from US FDA but by and large things have improved significantly from what it was couple of years back. In the two-wheeler space, Hero MotoCorp is definitely a stand out with the rural market getting a lot of attention as this is an election year. Drag according to your convenience. As global headwinds are being compensated to some extent by domestic positive factors, the market is not crashing anytime soon. How are you looking at the auto space? This will alert our moderators to nuy-pharma action. Yes, there may be sporadic action here and there from US FDA but by and large things have improved significantly from what it was couple of years back. Do you believe that we can hold our head above the 10, mark? Could buy-pharma like the currency and improvement in US business prove to be tailwinds for the sector as a whole? What is your assessment of the pharma pack as a whole? As far as domestic issues are concerned, we are by and large buy-phsrma a favourable territory. Will be displayed Will buy-pharma be displayed Will be displayed, buy-pharma.

As you rightly pointed out US business is improving and to a great extent the regulatory action is also behind the industry. Get instant notifications from Economic Times Allow Not now You can switch off notifications anytime using browser settings. Fill in your details: The spectacles and watch businesses have started performing well. How are you looking at the auto space? Never miss a great news story! It has not performed as a sector for quite some time. Hero with its outstanding reach in the rural market should benefit and they should be the outperformers amongst the two-wheeler companies. We have been bullish on auto. Get instant notifications from Economic Times Allow Not now. Most of the companies have tried to get their act together. But our strategy has been very clearly to buy a basket of pharma companies so that you avoid the vagaries of individual company related regulatory action. For an investor in a volatile market with depreciating currency, pharma definitely is a good bet. It is a good company to buy into but between the two-wheeler companies, we will go for Hero MotoCorp. Things are just simmering and a few noises are being made which are bit unsettling. They came up with excellent results. What do you think could fuel the rise of the markets even further? Monsoon has been generally good. Overall, the market is on tenterhooks. It has corrected significantly from where it was and their core business is doing fantastically well. Most of the companies buy-pharma tried to get their act together. However, it is not going to move up sharply in a hurry either. But the stock has been beaten down in recent past. As far as domestic issues are concerned, we are by and large in a favourable territory.

Author: